1Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol, 1987,22:724-729.
2Serretti A, Olgiati P, De Ronchi D. Genetics of Alzheimer's disease. A rapidly evolving field. J Alzheimer's Dis,2007,12:73-92.
4Cummings JL, Vinters HV, Cole GM, et al. Alzheimer's disease: etiologies, pathophysiology,cognitive reserve, and treatment opportunities. Neurology,1998,51 :S2-17.
5Kaye JA. Diagnostic challenges in dementia. Neurology,, 1998,51: S45-52.
6Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol, 1991, 82:239-259.
7Hardy J, Selkoc DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road Io therapeutics. Science,2002, 297 : 353-356.
8Cummings JL. Alzheimer's disease. N Engl J Med,2004, 351:56-67.
9Roher AE, Weiss N, Kokjohn TA, et al. Increased A beta peptide and reduced cholesterol anti myelin protein characterize white matter degeneration in Alzheimer's disease. Biochemistry,2002, 41:11080- 11090.
10Citron M, Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci,2004, 5:677-685.
